Loading market dashboard
ANI Pharmaceuticals, Inc.
ANIPHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ANI Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.57B | $1.52B - $1.64B | $647.31M | $15.207 | 2 |
| Dec 2029 | $1.42B | $1.37B - $1.48B | $585.52M | $13.648 | 2 |
| Dec 2028 | $1.31B | $1.29B - $1.34B | $542.13M | $12.792 | 5 |
| Dec 2027 | $1.25B | $1.21B - $1.32B | $516.00M | $10.737 | 5 |
| Dec 2026 | $1.12B | $1.11B - $1.17B | $463.95M | $9.371 | 5 |
| Dec 2025 | $867.39M | $866.39M - $868.07M | $358.50M | $7.537 | 5 |
| Dec 2024 | $599.19M | $597.59M - $600.49M | $247.65M | $5.007 | 5 |
| Dec 2023 | $538.95M | $522.21M - $563.68M | $222.76M | $1.201 | 2 |
| Dec 2022 | $306.90M | $298.81M - $315.13M | $16.36M | $1.368 | 1 |
| Dec 2021 | $211.60M | $206.02M - $217.27M | $23.28M | $3.46 | 1 |
| Dec 2020 | $205.37M | $199.95M - $210.87M | $22.60M | $3.647 | 2 |
| Dec 2019 | $210.37M | $204.82M - $216.01M | $56.45M | $5.163 | 1 |